Coverart for item
The Resource Global health risk framework : research and development of medical products : workshop summary, Theresa Wizemann, Michelle A. Mancher, and Anne B. Claiborne, rapporteurs ; Board of Health Sciences Policy, Institute of Medicine, the National Academies of Sciences, Engineering, Medicine

Global health risk framework : research and development of medical products : workshop summary, Theresa Wizemann, Michelle A. Mancher, and Anne B. Claiborne, rapporteurs ; Board of Health Sciences Policy, Institute of Medicine, the National Academies of Sciences, Engineering, Medicine

Label
Global health risk framework : research and development of medical products : workshop summary
Title
Global health risk framework
Title remainder
research and development of medical products : workshop summary
Statement of responsibility
Theresa Wizemann, Michelle A. Mancher, and Anne B. Claiborne, rapporteurs ; Board of Health Sciences Policy, Institute of Medicine, the National Academies of Sciences, Engineering, Medicine
Creator
Contributor
Issuing body
Subject
Genre
Language
eng
Summary
Since the 2014 Ebola outbreak many public- and private-sector leaders have seen a need for improved management of global public health emergencies. The effects of the Ebola epidemic go well beyond the three hardest-hit countries and beyond the health sector. Education, child protection, commerce, transportation, and human rights have all suffered. The consequences and lethality of Ebola have increased interest in coordinated global response to infectious threats, many of which could disrupt global health and commerce far more than the recent outbreak. In order to explore the potential for improving international management and response to outbreaks the National Academy of Medicine agreed to manage an international, independent, evidence-based, authoritative, multistakeholder expert commission. As part of this effort, the Institute of Medicine convened four workshops in summer of 2015 to inform the commission report. The presentations and discussions from the Workshop on Research and Development of Medical Products are summarized in this report
Cataloging source
NLM
http://library.link/vocab/creatorName
Wizemann, Theresa M
Dewey number
614.4
Funding information
This activity was supported by Sponsor Award No. 11849 from the Paul G. Allen Family Foundation, Grant No. 0150-0653 from the Ford Foundation, Investment ID OPP1130763 from The Bill & Melinda Gates Foundation, Dr. Ming Wai Lau, Grant No. 4829 from the Gordon and Betty Moore Foundation, Grant No. 2015 EBO 308 from The Rockefeller Foundation, Award No. GHN-G-00-07-00001-00 from the U.S. Agency for International Development, and the Wellcome Trust. Any opinions, findings, conclusions, or recommendations expressed in this publication do not necessarily reflect the views of any organization or agency that provided support for the project.
Index
no index present
LC call number
RA651
LC item number
.W594 2016eb
Literary form
non fiction
Nature of contents
  • dictionaries
  • bibliography
  • technical reports
NLM call number
  • 2016 F-679
  • WA 110
http://bibfra.me/vocab/relation/rapporteur
  • hJabFGAjvrk
  • bY3R2Lhk4Qk
  • EEmUXLUVgRc
http://library.link/vocab/relatedWorkOrContributorDate
2015
http://library.link/vocab/relatedWorkOrContributorName
  • Mancher, Michelle
  • Claiborne, Anne B.
  • Institute of Medicine (U.S.)
  • National Academies of Sciences, Engineering, and Medicine (U.S.)
  • Global Health Risk Framework: Research and Development of Medical Products (Workshop)
http://library.link/vocab/subjectName
  • Diseases
  • World health
  • Epidemiology
  • Mortality
  • Communicable Disease Control
  • Drug Discovery
  • Global Health
  • International Cooperation
  • Pandemics
  • Vaccines
  • MEDICAL
  • MEDICAL
  • MEDICAL
  • Diseases
  • Epidemiology
  • Mortality
  • World health
Label
Global health risk framework : research and development of medical products : workshop summary, Theresa Wizemann, Michelle A. Mancher, and Anne B. Claiborne, rapporteurs ; Board of Health Sciences Policy, Institute of Medicine, the National Academies of Sciences, Engineering, Medicine
Instantiates
Publication
Note
Workshop agenda, August 19-21, 2015, Cheung Kung Hai Conference Centre, Hong Kong
Bibliography note
Includes bibliographical references
Carrier category
online resource
Carrier category code
  • cr
Carrier MARC source
rdacarrier
Color
black and white
Content category
text
Content type code
  • txt
Content type MARC source
rdacontent
Contents
Introduction -- Models and incentives for engagement -- Discovery research -- Development -- Convergence of regulatory expections, review, and approval -- Manufacturing, stockpiling, and distribution -- Critical considerations for facilitating medical product research and development -- Crosscutting themes and closing remarks -- Appendix A: References -- Appendix B: Workshop statement of task -- Appendix C: Workshop agenda -- Appendix D: Workshop speaker biographies
Control code
949829885
Dimensions
unknown
Extent
1 online resource (1 PDF file (xvi, 123 pages))
Form of item
online
Isbn
9780309381000
Media category
computer
Media MARC source
rdamedia
Media type code
  • c
Specific material designation
remote
System control number
(OCoLC)949829885
Label
Global health risk framework : research and development of medical products : workshop summary, Theresa Wizemann, Michelle A. Mancher, and Anne B. Claiborne, rapporteurs ; Board of Health Sciences Policy, Institute of Medicine, the National Academies of Sciences, Engineering, Medicine
Publication
Note
Workshop agenda, August 19-21, 2015, Cheung Kung Hai Conference Centre, Hong Kong
Bibliography note
Includes bibliographical references
Carrier category
online resource
Carrier category code
  • cr
Carrier MARC source
rdacarrier
Color
black and white
Content category
text
Content type code
  • txt
Content type MARC source
rdacontent
Contents
Introduction -- Models and incentives for engagement -- Discovery research -- Development -- Convergence of regulatory expections, review, and approval -- Manufacturing, stockpiling, and distribution -- Critical considerations for facilitating medical product research and development -- Crosscutting themes and closing remarks -- Appendix A: References -- Appendix B: Workshop statement of task -- Appendix C: Workshop agenda -- Appendix D: Workshop speaker biographies
Control code
949829885
Dimensions
unknown
Extent
1 online resource (1 PDF file (xvi, 123 pages))
Form of item
online
Isbn
9780309381000
Media category
computer
Media MARC source
rdamedia
Media type code
  • c
Specific material designation
remote
System control number
(OCoLC)949829885

Library Locations

  • Health Sciences LibraryBorrow it
    2411 Holmes St, Kansas City, Kansas City, MO, 64108, US
    39.083418 -94.575323
  • LaBudde Special CollectionsBorrow it
    800 E 51st St, Kansas City, MO, 64110, US
    39.034642 -94.576835
  • Leon E. Bloch Law LibraryBorrow it
    500 E. 52nd Street, Kansas City, MO, 64110, US
    39.032488 -94.581967
  • Marr Sound ArchivesBorrow it
    800 E 51st St, Kansas City, MO, 64110, US
    39.034642 -94.576835
  • Miller Nichols LibraryBorrow it
    800 E 51st St, Kansas City, MO, 64110, US
    39.035061 -94.576518
  • UMKCBorrow it
    800 E 51st St, Kansas City, MO, 64110, US
    39.035061 -94.576518
  • UMKCBorrow it
    800 E 51st St, Kansas City, MO, 64110, US
Processing Feedback ...